Cargando…

Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH

miRNAs are involved in the development of metabolic associated fatty liver disease (MAFLD) and nonalcoholic steatohepatitis (NASH). We aimed to evaluate modifications by prolonged-release pirfenidone (PR-PFD) on key hepatic miRNAs expression in a MAFLD/NASH model. First, male C57BL/6J mice were rand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Escutia-Gutiérrez, Rebeca, Rodríguez-Sanabria, J. Samael, Monraz-Méndez, C. Alejandra, García-Bañuelos, Jesús, Santos-García, Arturo, Sandoval-Rodríguez, Ana, Armendáriz-Borunda, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175718/ https://www.ncbi.nlm.nih.gov/pubmed/34083664 http://dx.doi.org/10.1038/s41598-021-91187-2

Ejemplares similares

Moringa oleifera Improves MAFLD by Inducing Epigenetic Modifications
por: Monraz-Méndez, C. Alejandra, et al.
Publicado: (2022)

An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease
por: Rodríguez-Sanabria, J. Samael, et al.
Publicado: (2022)

Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2021)

Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK
por: Sandoval‐Rodriguez, Ana, et al.
Publicado: (2020)

Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
por: Sandoval-Rodriguez, Ana, et al.
Publicado: (2022)

The multifaceted role of pirfenidone and its novel targets
por: Macías-Barragán, José, et al.
Publicado: (2010)

Dietary supplementation with Mexican foods, Opuntia ficus indica, Theobroma cacao, and Acheta domesticus: Improving obesogenic and microbiota features in obese mice
por: Rosas-Campos, Rebeca, et al.
Publicado: (2022)

Mexican Ancestral Foods (Theobroma cacao, Opuntia ficus indica, Persea americana and Phaseolus vulgaris) Supplementation on Anthropometric, Lipid and Glycemic Control Variables in Obese Patients: A Systematic Review and Meta-Analysis
por: Escutia-Gutiérrez, Rebeca, et al.
Publicado: (2023)

Advances of Nanotechnology in the Diagnosis and Treatment of Hepatocellular Carcinoma
por: Escutia-Gutiérrez, Rebeca, et al.
Publicado: (2023)

Pirfenidone Protects from UVB-Induced Photodamage in Hairless Mice
por: Martinez-Alvarado, Yocasta, et al.
Publicado: (2023)

Pirfenidone Accelerates Wound Healing in Chronic Diabetic Foot Ulcers: A Randomized, Double-Blind Controlled Trial
por: Gasca-Lozano, Luz E., et al.
Publicado: (2017)

Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2022)

TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism
por: Shepard, Christopher R.
Publicado: (2021)

Simultaneous Administration of ADSCs-Based Therapy and Gene Therapy Using Ad-huPA Reduces Experimental Liver Fibrosis
por: Meza-Ríos, Alejandra, et al.
Publicado: (2016)

Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2021)

The Role of NRF2 in Obesity-Associated Cardiovascular Risk Factors
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2022)

Hepatocarcinogenesis Prevention by Pirfenidone Is PPARγ Mediated and Involves Modification of Nuclear NF-kB p65/p50 Ratio
por: Silva-Gomez, Jorge Antonio, et al.
Publicado: (2021)

Role and New Insights of Pirfenidone in Fibrotic Diseases
por: Lopez-de la Mora, David Alejandro, et al.
Publicado: (2015)

Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases
por: Griffett, Kristine, et al.
Publicado: (2023)

Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C
por: Flores-Contreras, Lucia, et al.
Publicado: (2014)

MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
por: Segura-Azuara, Nancy de los Ángeles, et al.
Publicado: (2022)

Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction
por: Lonardo, Amedeo, et al.
Publicado: (2022)

Fibrosis regression is induced by AdhMMP8 in a murine model of chronic kidney injury
por: Contreras-Salinas, Homero, et al.
Publicado: (2020)

Correction: Human adipose derived stem cells regress fibrosis in a chronic renal fibrotic model induced by adenine
por: Rivera-Valdés, Juan José, et al.
Publicado: (2018)

Human adipose derived stem cells regress fibrosis in a chronic renal fibrotic model induced by adenine
por: Rivera-Valdés, Juan José, et al.
Publicado: (2017)

Delphinidin Ameliorates Hepatic Triglyceride Accumulation in Human HepG2 Cells, but Not in Diet-Induced Obese Mice
por: Parra-Vargas, Marcela, et al.
Publicado: (2018)

Effect of Prolonged-Release Pirfenidone on Renal Function in Septic Acute Kidney Injury Patients: A Double-Blind Placebo-Controlled Clinical Trial
por: Chávez-Iñiguez, Jonathan S., et al.
Publicado: (2021)

PPARs as Metabolic Sensors and Therapeutic Targets in Liver Diseases
por: Monroy-Ramirez, Hugo Christian, et al.
Publicado: (2021)

Topical Pirfenidone-Loaded Liposomes Ophthalmic Formulation Reduces Haze Development after Corneal Alkali Burn in Mice
por: Diaz-Palomera, Carlos Daniel, et al.
Publicado: (2022)

Molecular Basis and Current Treatment for Alcoholic Liver Disease
por: Miranda-Mendez, Alejandra, et al.
Publicado: (2010)

AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis
por: García-Bañuelos, Jesús, et al.
Publicado: (2023)

Screening for MAFLD: who, when and how?
por: Pal, Shreya C., et al.
Publicado: (2023)

Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
por: Udoh, Utibe-Abasi S., et al.
Publicado: (2022)

Therapies Based on Nanoparticles for Eye Drug Delivery
por: Meza-Rios, Alejandra, et al.
Publicado: (2020)

Toward a New Generation of Bio-Scaffolds for Neural Tissue Engineering: Challenges and Perspectives
por: Villanueva-Flores, Francisca, et al.
Publicado: (2023)

Oxidative and Fibrinolytic Mechanisms: Two Important Processes to Consider in Platelet Storage
por: Garcia-Bañuelos, Jesus Javier, et al.
Publicado: (2023)

Hydrodynamics-based liver transfection achieves gene silencing of CB1 using short hairpin RNA plasmid in cirrhotic rats
por: Díaz-Rivera, Adriana, et al.
Publicado: (2020)

Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study
por: Gonzalez-De la Rosa, Alejandro, et al.
Publicado: (2019)

Pirfenidone: is it tolerable?
por: Lara, Abigail, et al.
Publicado: (2016)

Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study
por: Poo, Jorge Luis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k8g865nv8tm9lrkvmrkkga2bla